Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Feb 13, 2026
Reporting period
Not applicable
Filed with the SEC
Feb 18, 2026
OfficerTax withholding
Context
Classification
tax withholding
Code F — shares delivered to pay exercise price or tax liability
Planned / mechanical clue
Tax mechanics (code F)
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001628280-26-009283
Filed / recorded
Feb 18, 2026, 10:44 PM UTC
Added to OQRO
Oct 8, 2026, 12:30 AM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
ADC Therapeutics SA
Issuer CIK
1771910
Ticker
ADCT
Reporting person
Lisa Michelle Kallebo
Relationship
Officer
Officer title
Chief Accounting Officer
Security
Common Shares
Table
Non-derivative (Table I)
Transaction date
Feb 13, 2026
Transaction code
F
Shares / units
5,433
Price per share
$3.99
Acquired / disposed
Disposed (D)
Shares owned after
128,224
Ownership form
Direct
Amendment
No
Footnotes from the filing
Represents the number of Common Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted share units previously granted.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.